Effettuare il login Iscriviti gratis

Intercept Pharmaceuticals Inc Avanti P/E

Cos'è Avanti P/E di Intercept Pharmaceuticals Inc?

Avanti P/E di Intercept Pharmaceuticals Inc è -5.54

Qual è la definizione di Avanti P/E?



Il rapporto prezzo / utili a termine è il rapporto tra il prezzo delle azioni di una società e l'utile stimato per azione della società per i prossimi dodici mesi.

The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.

Avanti P/E di aziende nel Health Care settore su NASDAQ rispetto a Intercept Pharmaceuticals Inc

Cosa fa Intercept Pharmaceuticals Inc?

we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.

Aziende con avanti p/e simili a Intercept Pharmaceuticals Inc